Header Logo

STEPHEN PAPPAS

Concepts (64)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatorenal Syndrome
11
2023
27
2.680
 Why?
Vasoconstrictor Agents
10
2023
137
1.050
 Why?
Lypressin
8
2023
15
0.770
 Why?
Hepatitis B
1
2021
160
0.680
 Why?
Duty to Warn
1
2019
2
0.640
 Why?
Professional Impairment
1
2019
3
0.640
 Why?
Alcoholic Intoxication
1
2019
11
0.630
 Why?
Confidentiality
1
2019
101
0.600
 Why?
Hepatitis C Antibodies
1
2017
21
0.580
 Why?
Kidney Function Tests
2
2017
126
0.570
 Why?
Alcoholism
1
2019
230
0.530
 Why?
Diagnostic Tests, Routine
1
2017
117
0.520
 Why?
Hepacivirus
1
2017
241
0.510
 Why?
Albumins
6
2023
89
0.460
 Why?
Liver Cirrhosis
5
2023
832
0.260
 Why?
Liver Transplantation
3
2023
1036
0.220
 Why?
Respiratory Insufficiency
2
2022
231
0.210
 Why?
Hepatitis, Alcoholic
1
2023
26
0.200
 Why?
Hepatitis B Antibodies
1
2021
24
0.190
 Why?
Hepatitis B Vaccines
1
2021
41
0.190
 Why?
Acute-On-Chronic Liver Failure
1
2022
64
0.190
 Why?
Hepatitis B virus
1
2021
136
0.180
 Why?
Liver Cirrhosis, Alcoholic
1
2019
36
0.160
 Why?
Hepatic Encephalopathy
1
2019
75
0.150
 Why?
Safety
1
2019
218
0.150
 Why?
Drug Therapy
1
2017
85
0.140
 Why?
Health Personnel
1
2021
504
0.130
 Why?
Humans
15
2023
124270
0.130
 Why?
Alcohol Drinking
1
2019
339
0.130
 Why?
Self Report
1
2019
517
0.130
 Why?
Patient Education as Topic
1
2019
443
0.120
 Why?
Surgical Procedures, Operative
1
2017
181
0.120
 Why?
Systemic Inflammatory Response Syndrome
1
2016
173
0.120
 Why?
Interdisciplinary Communication
1
2016
134
0.120
 Why?
Interprofessional Relations
1
2016
144
0.120
 Why?
Hepatitis C
1
2017
364
0.110
 Why?
Metabolomics
1
2017
417
0.110
 Why?
Information Dissemination
1
2016
189
0.110
 Why?
Acute Kidney Injury
1
2020
624
0.110
 Why?
Gastrointestinal Diseases
1
2016
334
0.100
 Why?
Disease Progression
1
2017
2037
0.090
 Why?
Renal Replacement Therapy
2
2023
142
0.090
 Why?
Treatment Outcome
6
2023
12264
0.080
 Why?
Biomarkers
1
2019
2974
0.080
 Why?
Physicians
1
2016
584
0.080
 Why?
Double-Blind Method
2
2021
1614
0.070
 Why?
Canada
2
2016
294
0.060
 Why?
Drug Therapy, Combination
2
2017
1154
0.050
 Why?
Middle Aged
5
2021
26367
0.050
 Why?
Infusions, Intravenous
1
2021
548
0.040
 Why?
Combined Modality Therapy
1
2021
1244
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2017
66
0.030
 Why?
Placebos
1
2016
241
0.030
 Why?
Male
5
2021
60887
0.030
 Why?
Survival Rate
1
2020
2018
0.030
 Why?
Female
5
2021
66294
0.030
 Why?
Survival Analysis
1
2016
1478
0.030
 Why?
Randomized Controlled Trials as Topic
1
2017
1096
0.020
 Why?
Prognosis
1
2020
4548
0.020
 Why?
Aged
2
2020
19386
0.020
 Why?
Kidney
1
2016
1346
0.020
 Why?
Adult
2
2017
29357
0.020
 Why?
United States
1
2016
10756
0.010
 Why?
Retrospective Studies
1
2016
16214
0.010
 Why?
PAPPAS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (64)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_